Načítá se...
Novel strategies for patients with chronic myeloproliferative disorders
PURPOSE OF REVIEW: This review focuses on new strategies for unmet clinical needs and on new targeted therapies in classical Philadelphia-negative myeloproliferative neoplasms (MPNs). RECENT FINDINGS: Meta-analyses in essential thrombocythemia (ET) documented JAK2 V617F being associated with increas...
Uloženo v:
| Vydáno v: | Curr Opin Hematol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6368353/ https://ncbi.nlm.nih.gov/pubmed/19468275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOH.0b013e3283257a9e |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|